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Edited by Lukas HuberAbstract Cbl-interacting protein of 85 kDa (CIN85) is a
recently identiﬁed adaptor protein involved in the endocytic
process of several receptor tyrosine kinases. Here we have
identiﬁed a novel RhoGAP, CIN85 associated multi-domain
containing RhoGAP1 (CAMGAP1) as a binding protein for
CIN85. CAMGAP1 is composed of an Src homology 3 (SH3)
domain, multiple WW domains, a proline-rich region, a PH
domain and a RhoGAP domain, and has the domain architecture
similar to ARHGAP9 and ARHGAP12. CAMGAP1 mRNA is
widely distributed in murine tissues. Biochemical assays showed
its GAP activity toward Rac1 and Cdc42. Protein binding and
expression studies indicated that the second SH3 domain of
CIN85 binds to a proline-rich region of CAMGAP1. Overex-
pression of a truncated form of CAMGAP1 interferes with the
internalization of transferrin receptors, suggesting that CAM-
GAP1 may play a role in clathrin-mediated endocytosis.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cbl-interacting protein of 85 kDa (CIN85) is a recently dis-
covered protein that interacts with Cbl proto-oncogene product
and contains three Src homology 3 (SH3) domains, a proline-
rich region and a coiled-coil region [1,2]. Recent works have
shown that CIN85 is involved in the regulation of clathrin-
mediated endocytosis of several plasma membrane receptors
[2–4]. Upon ligand binding activated receptor tyrosine kinases
such as epidermal growth factor and hepatocyte growth factor
receptors associate with and phosphorylate Cbl family of
ubiquitin ligases, which in turn ubiquitinates the activated re-
ceptors. The phosphorylation of Cbl confers the increased
binding to the SH3 domains of CIN85. The proline-rich region
of CIN85 is constitutively associated with endophilin, an ac-
cessory endocytic protein implicated in invagination of the* Corresponding author. Fax: +81-22-217-8090.
E-mail address: ynemoto@mail.cc.tohoku.ac.jp (Y. Nemoto).
Abbreviations: GAP, GTPase activating protein; CIN85, Cbl-interact-
ing protein of 85 kDa; SH3, Src homology 3; PH, pleckstrin homology;
CHO, Chinese hamster ovary; GST, glutathione S-transferase; MBP,
maltose binding protein; PAGE, polyacrylamide gel electrophoresis;
HA, hemagglutinin; kb, kilobase(s)
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doi:10.1016/j.febslet.2004.03.101plasma membrane during the early steps of clathrin-mediated
endocytosis and the recruitment of other endocytic proteins
including dynamin and synaptojanin. CIN85 thus functions as
an adaptor protein that brings the endocytic machinery in the
vicinity of membrane receptors in a stimulation-dependent
manner.
Growing evidence indicates a functional link between
clathrin-mediated endocytosis and actin cytoskeleton in
mammalian cells [5,6]. Several components in the endocytic
machinery interact with F-actin or with activators of Arp2/3-
dependent actin polymerization [6,7]. Perturbations in actin
assembly and disassembly by toxin treatment inhibit receptor-
mediated endocytosis in some cell lines [8,9]. Although several
roles for actin dynamics in receptor-mediated endocytosis are
proposed, its precise function in the process remains unclear.
In an attempt to elucidate the mechanism of clathrin-medi-
ated endocytosis of the plasma membrane proteins, we further
looked for binding proteins for CIN85 by employing yeast two
hybrid screen. We identiﬁed a novel member of RhoGAPs, a
family of proteins accelerating the GTPase activity of Rho
GTPases and thereby regulating their activities.2. Materials and methods
2.1. Yeast two hybrid screen and isolation of CAMGAP1 cDNA
Molecular cloning of rat CIN85 cDNA as a binding protein for rat
endophilin 2 will be described elsewhere. The DNA fragment encoding
the amino-terminal SH3 domains of rat CIN85 (amino acids 1–381)
was ampliﬁed by PCR from the cloned cDNA and subcloned into
pBTM116 [10], and the plasmid was used as bait to screen a rat brain
cDNA library constructed in pGAD10 vector (Clontech) as described
[11]. Among 5 106 TRPþLEUþ transformants, 89 HISþLacZþ
clones were selected which interacted speciﬁcally with the SH3 do-
mains of rat CIN85. By restriction mapping and partial sequence
analysis, 42 of them were found to be independent isolates of four
overlapping cDNAs. To obtain the full-length cDNA, the insert DNA
fragment was radiolabelled with [a-32P]dCTP (Amersham Pharmacia
Biotec) by oligolabelling method and used as probe for screening of a
rat brain cDNA library constructed in kZAPII (Stratagene) following
standard techniques [12].
2.2. Northern blot analysis
Murine Poly(A)þ RNA Northern Blots (OriGene Technologies)
were probed for three CAMGAPs under stringent condition [12]. A
612-bp DNA fragment spanning three WW domains of murine
CAMGAP1 (amino acids 230–433), a 621-bp fragment corresponding
to the N-terminal portion of murine homologue of CAMGAP2/
ARHGAP12 (amino acids 3–209) and a 618-bp fragment corre-
sponding to a region between the WW domain and the pleckstrinblished by Elsevier B.V. All rights reserved.
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acids 253–458) were obtained by PCR using total RNA isolated from
adult mouse brain. The DNA fragments were radiolabelled and used
as probes. The hybridized blots were exposed to KODAK X-ray ﬁlms
with intensifying screens at )80 C for 24 h.
2.3. Fusion protein production, protein binding assays and
immunoprecipitation
The PCR-generated fragments encoding various portions of rat
CAMGAP1 and the SH3 domains of rat CIN85 (SH3-A, amino acids
1–67; SH3-B, amino acids 96–171; SH3-C, amino acids 306–379) were
subcloned into pGEX4T-1 (Amersham Pharmacia Biotec) or pMalC2
vector (New England Biolabs). The glutathione S-transferase (GST)
fusion proteins were expressed in E. coli DH5a and puriﬁed by glu-
tathione Sepharose 4B column chromatography following the manu-
facturer’s instructions. The maltose binding protein (MBP) fusion
proteins were expressed in E. coli DH5a and puriﬁed by amylose resin
(New England Biolabs). The purity of protein preparations was
checked on Coomassie blue-stained SDS–polyacrylamide gel electro-
phoresis (PAGE). Aﬃnity puriﬁcation with the immobilized re-
combinant proteins and immunoprecipitation from Triton extracts of
rat brain and Chinese hamster ovary (CHO) and COS-7 cell lysatesFig. 1. Primary structure of rat CAMGAP1. (A) The deduced amino acid se
follows: single underline, SH3 domain; open boxes, WW domain; dashed und
black box, RhoGAP domain. The sequence data are available from Genba
RhoGAP domains from rat CAMGAP1, human ARHGAP12 (AAK52311
protein (BCR) (P11274), human N-chimaerin (P15882), human p115 rhoGA
CAMGAP1 are shown by black boxes. Gaps are indicated by dashes. Clustal W
the domain structure of rat CAMGAP1 and the homologues. Human C
BX400801, BX328361, BX279931 and BQ709443.Murine CAMGAP1 is comp
and BU898711, murine CAMGAP2 from BU51689, BU696071, BQ831585,
BI249799, BB651844, BF137452 and BB34371. The amino-terminal region of
ESTs, AA542262 and BI249799. The unknown regions in murine CAMGAPwere performed as described [11]. For blot overlay, protein samples
were separated by 10% SDS–PAGE and transferred onto nitrocellu-
lose membranes. The membranes were probed with GST fusion pro-
teins (2 lg/ml) for 2 h at room temperature and bound proteins were
detected by rabbit anti-GST antibody as described [13].
2.4. In vitro GTPase activating protein (GAP) activity assay
The procedures essentially followed the methods described previ-
ously [14]. Brieﬂy, the GST fusion proteins of rat CAMGAP1 Rho-
GAP domain (amino acids 668–869), human RhoA, Rac1 and Cdc42
were prepared as described above. The puriﬁed GST-RhoA, Rac1 and
Cdc42 were incubated at 30 C for 10 min in 100 ll of buﬀer containing
50 mM Tris–HCl, pH 7.6, 50 mM NaCl, 5 mMMgCl2, 10 mM EDTA
and 5 mM dithiothreitol and 10 lCi of [c-32P]GTP (Amersham
Pharmacia Biotec). The preloaded GST-tagged GTPase (0.1 lg) was
incubated with or without GST-GAP protein in GAP assay buﬀer
containing 50 mM Tris–HCl, pH 7.6, 50 mM NaCl, 5 mM MgCl2 and
5 mM dithiothreitol at 25 C for the indicated time. The reactions were
terminated by adding 1 ml of ice-cold GAP assay buﬀer and ﬁltered
through nitrocellulose membranes (Schleicher & Schuell). The radio-
activity retained on the membranes was measured by liquid scintilla-
tion counting.quence of rat CAMGAP1. The domains in CAMGAP1 are shown as
erline, CIN85 binding proline-rich region; shadowed box, PH domain;
nk/EMBL/DDBJ under Accession No. AY394725. (B) Alignment of
), human ARHGAP9 (BAB56159), human breakpoint cluster region
P (P98171) and human p50 rhoGAP (Q07960). Identical residues with
program was used to create the alignment. (C) Schematic diagrams of
AMGAP1 is compiled from ESTs BQ049142, AI972838, BI906615,
iled from ESTs BY717416, BI103060, AI786575, BE307041, BG963022
CA751353, BB861743 and CD773071, and murine CAMGAP3 from
murine CAMGAP3 was determined by PCR using the primers based on
1 and 3 are indicated by dashes. Pro; proline-rich region.
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For the cell expression of the various portions of CAMGAP1, the
PCR-generated fragments encoding the domains were subcloned in
pHA, a modiﬁed pcDNA3 vector for production of N-terminal hem-
agglutinin (HA)-tagged proteins [15]. The DNA fragment encoding
full-length N-terminal FLAG-tagged rat CIN85 was subcloned into
pTRE (Clontech) to form pTRE-FLAG CIN85, the plasmid produc-
ing N-terminal FLAG-tagged CIN85 protein under the control of a
tetracycline-regulated promoter.
2.6. Cell culture and generation of tetracycline-inducible CHO cell lines
CHO and COS-7 cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum, 100 U/ml peni-
cillin G and 100 lg/ml streptomycin sulfate. CHO cells expressing
FLAG-tagged rat CIN85 under the control of a tetracycline-responsive
promotor were generated by using Tet-On gene expression system es-
sentially as described by the vendor (Clontech). Brieﬂy, CHO cells were
transfected with pTet-On for expression of tetracycline-regulated ac-
tivator rtTA. The rtTA function in the neomycin-resistant clones was
tested by using the reporter plasmid pTRE-luc. The selected CHO
clone was transfected with pTRE-FLAG CIN85 and pPUR. After
selection in neomycin (200 lg/ml) (Nacalai tesque) and puromycin (5
lg/ml) (Sigma), the protein expression in the isolated clones was in-
duced by addition of 2 lg/ml doxycycline (Clontech) and tested for
CIN85 expression by immunoblotting.
2.7. Immunoﬂuorescence microscopy
CHO or COS-7 cells were grown on coverslips and transfected with
the expression plasmids using lipofectamine following the manufac-
turer’s instructions (Invitrogen). Coverslips were ﬁxed and processed
for indirect immunoﬂuorescence as described [16]. The coverslips were
mounted in Vectashield (Vector Laboratories) and examined with anFig. 2. Northern blot analysis of murine CAMGAPs. A murine mul-
tiple tissue Northern blot was hybridized with the speciﬁc probes for
CAMGAP1 (A), CAMGAP2 (B) and CAMGAP3 (C). Numbers on
the left indicate the positions of the molecular markers in kilobase
(kb). The minor 6-kb band in spleen and thymus in (C) is observed
only after a long exposure.epiﬂuorescent microscope Olympus BX60 in Fig. 5A or a confocal
microscope Olympus IX70 in Fig. 6.
2.8. Antibody
A rabbit polyclonal antibody against rat CIN85 was gener-
ated against a C-terminal 18-amino acid synthetic peptide
(RLRLQMEVNDIKKALQSK) coupled via cysteine at the amino-
terminal residue to keyhole limpet hemocyanin following the standard
procedure [17]. The antiserum was puriﬁed by the peptide covalently
coupled to SulfoLink coupling gel (Pierce). Mouse monoclonal anti-
FLAG antibody M5 was obtained from Sigma. Rabbit polyclonal
anti-MBP antibody N-17 was from Santa Cruz Biotechnology. Mouse
monoclonal anti-HA antibody 12CA5 and rabbit polyclonal anti-HA
antibody Y-11 were from Babco and Santa Cruz Biotechnology,
respectively.
2.9. Miscellaneous
Procedures for SDS–PAGE and immunoblotting were as described
[15]. Protein concentrations were determined by the method of Brad-
ford [18] using bovine serum albumin as standard. PCR was performed
by using Vent polymerase (New England Biolabs). The primer se-
quences used in this study are available upon request. The integrity of
the PCR-derived fragments was veriﬁed by nucleotide sequencing with
an ABI Prism 310 DNA sequencer before introducing into the ap-
propriate vectors. Transferrin uptake experiment followed the proce-
dure described previously [19].3. Results and discussion
By yeast two hybrid screen for a CIN85-binding protein
using rat brain cDNA libraries, the cDNA potentially en-
coding a new RhoGAP domain-containing protein was iso-Fig. 3. CAMGAP1 has GTPase activating activity toward Rac1 and
Cdc42 in vitro. (A) The GTPase activities of RhoA, Rac1 and Cdc42
were measured in the presence (solid line) or absence (dashed line) of
the GST-RhoGAP domain of CAMGAP1 (0.25 lg). (B) GTPase ac-
tivities were measured in the presence of various amounts of GST-
RhoGAP domain for 5 min. In both panels, the values for RhoA, Rac1
and Cdc42 are indicated by red, green and blue lines, respectively.
Results are expressed as meansS.D. of three independent experi-
ments.
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a protein of 869 amino acids with a predicted Mr of 96.3 which
we termed CIN85 associated multi-domain containing
RhoGAP 1 (CAMGAP1) (Fig. 1A). Sequence analysis re-
vealed that the carboxy-terminal region of this novel protein
(amino acids 688–863) exhibits a high degree of similarity to
several members of mammalian RhoGAP, especially to the
GAP domains of two recently found proteins, ARHGAP9 and
ARHGAP12 (50% and 62% amino acid identities, respec-
tively) (Fig. 1B) [20,21]. Besides the RhoGAP domain,
CAMGAP1 contains several functional domains; from its
amino- to carboxy-terminus, an SH3 domain, three WW do-
mains, a proline-rich region and a PH domain (Fig. 1A).Fig. 4. In vitro binding between the proline-rich region of CAMGAP1 and t
Lysates from COS-7 cells transiently expressing HA-tagged CAMGAP1 wer
(amino acids 96–171) and -C (amino acids 306–379) domains of CIN85 or GS
eluates were detected by SDS–PAGE and immunoblotting with anti-HA an
incubated with the immobilized GST fusion of various CAMGAP1 fragmen
475), SH3 (amino acids 1–78), PH (amino acids 459–698) and GAP (amino ac
detected by SDS–PAGE and immunoblotting with anti-CIN85 antibody. (C
MBP fusion proteins of the amino acids 101–475 (F1), amino acids 241–475 (
408–475 (F5) and amino acids 101–451 (R6) of CAMGAP1 were subjected
membrane was overlaid with GST-CIN85 SH3-B fusion protein and detect
MBP-fusion protein was loaded in each sample as detected by immunoblottin
of the molecular weight markers in kDa. (D) The summary of binding betwee
domain of CIN85 is indicated on the right.Notably, CAMGAP1, ARHGAP9 and ARHGAP12 have the
very similar domain structure with the diﬀerence being the
number of the WW domains (Fig. 1C). BLAST searches in-
dicate the presence of three human and murine CAMGAP
homologues. Thus, these three proteins deﬁne a novel sub-
family of mammalian RhoGAPs. We propose to call ARH-
GAP12 and ARHGAP9 as human CAMGAP2 and 3,
respectively.
The tissue distributions of these three CAMGAPs were de-
termined by Northern blot analysis. The CAMGAP1 probe
detected major two transcripts at 4.5 and 3.7 kb in a wide
range of murine tissues. The signals were especially abundant
in kidney, lung, small intestine and thymus (Fig. 2A). Thehe SH3-B domain of CIN85. (A) Aﬃnity puriﬁcation of CAMGAP1.
e incubated with the immobilized GST-SH3-A (amino acids 1–67), -B
T alone (control). HA-tagged CAMGAP1 in the lysates (input) and the
tibody. (B) Aﬃnity puriﬁcation of CIN85. The rat brain extract was
ts; SH3-3WW-Pro (amino acids 1–475), 3WW-Pro (amino acids 101–
ids 668–869). CIN85 in the rat brain extract (input) and the eluates were
) Mapping of CIN85 binding region in CAMGAP1. Top panel: The
F2), amino acids 294–475 (F3), amino acids 340–475 (F4), amino acids
to SDS–PAGE and transferred to the nitrocellulose membrane. The
ed by anti-GST antibody. Bottom panel: The comparable amount of
g using anti-MBP antibody. Numbers on the left indicate the positions
n the CAMGAP1 regions and CIN85. The binding ability to the SH3-B
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and 4.0-kb transcripts in heart, liver, skin, small intestine,
stomach and thymus, and smallest 1.3-kb transcript in testis
(Fig. 2B). The CAMGAP3 probe detected three transcripts at
2.8, 2.6 and 2.1 kb. The 2.8- and 2.1-kb transcripts were pre-
dominantly expressed in thymus and spleen (Fig. 2C). The
results suggest that three CAMGAPs are expressed as multiple
alternatively spliced forms with diﬀerent tissue distribution
and have distinct cellular functions in the expressed tissues
despite the structural similarity.
Each RhoGAP has GTPase activating activity toward the
speciﬁc member of Rho GTPase family [22]. To determine the
biochemical property of the C-terminal RhoGAP domain of
CAMGAP1, we measured the eﬀect of the GST fusion protein
of the GAP domain of rat CAMGAP1 expressed in E. coli on
the in vitro GTPase activity of RhoA, Rac1 and Cdc42. When
the GTP-bound Rho GTPases were incubated with the re-
combinant GAP domain of CAMGAP1, the intrinsic GTPase
activity of Rac1 and Cdc42, but not of RhoA, was signiﬁcantly
increased (Fig. 3A and B). The result is in line with the pre-
vious report for ARHGAP9/CAMGAP3 [20] and indicates
that rat CAMGAP1 exhibits GAP activity toward Rac1 and
Cdc42 among Rho family GTPases.
We performed biochemical experiments to conﬁrm the
binding between CAMGAP1 and CIN85. HA-tagged CAM-Fig. 5. Colocalization and binding between CAMGAP1 and CIN85 in CHO
tagged CIN85 and HA-tagged CAMGAP1 constructs. The expression of C
pression of CAMGAP1 fragment was detected by anti-HA antibody (green
proteins in the merged images (right column). (B) Co-immunoprecipitation
expressing FLAG-tagged CIN85 and HA-tagged CAMGAP1 constructs
Sepharose followed by immunoblotting with anti-HA antibody. Bottom panel
immunoblotting using anti-HA antibody. Numbers on the left indicate the pGAP1 was transiently expressed in COS-7 cells, and its binding
ability to GST-CIN85 SH3-A, -B and -C fusions was deter-
mined by pull-down experiments. As shown in Fig. 4A,
CAMGAP1 binds to the SH3-B domain of CIN85, but not to
the SH3-A and -C domains (Fig. 4A).
We generated the GST fusion proteins covering various
portions of CAMGAP1 and tested their binding to CIN85 in
rat brain. Western blotting with anti-CIN85 antibody revealed
that CIN85 binds to the region of CAMGAP1 containing
three WW domains and the proline-rich region (amino acids
101–475) (Fig. 4B). To ascertain the CIN85 binding region of
CAMGAP1, we made successive deletions of the CAMGAP1
region (amino acids 101–475) and tested the binding to the
GST-CIN85 SH3-B protein. The result indicates that a 24-
amino acid proline-rich sequence of CAMGAP1 (amino acids
452–475) is necessary for binding to the SH3-B domain of
CIN85 (Fig. 4C). Taken together, the biochemical binding
between CIN85 and CAMGAP1 is mainly mediated by the
SH3-B domain of CIN85 and the proline-rich region of
CAMGAP1.
Based on the biochemical experiments, we investigated the
intracellular binding between CAMGAP1 and CIN85 and
localization of CAMGAP1. Overexpression of CIN85 or the
closely related protein CMS/CD2AP has been reported to lead
to the formation of multiple punctate structures in COS-7cells. (A) Double immunoﬂuorescence of CHO cells expressing FLAG-
IN85 was detected by anti-FLAG antibody (red, left column). The ex-
, middle column). The yellow–orange color represents colocalization of
of CAMGAP1 and CIN85. Top panel: The lysates from CHO cells
were immunoprecipitated with anti-FLAG antibody and protein G
: The amount of HA-tagged proteins in each cell lysate was detected by
ositions of the molecular weight markers in kDa.
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partment [2,23–25]. Similar multiple punctate structures were
observed in CHO cells upon overexpression of CIN85
(Fig. 5A, left column). When CAMGAP1 was expressed in
CHO cells together with CIN85, the region of CAMGAP1
containing the proline-rich sequence (amino acids 452–475)
colocalized at the multiple punctate structures (Fig. 5A).
Moreover, immunoprecipitation of epitope-tagged CIN85Fig. 6. Transferrin uptake inhibition in CHO and COS-7 cells trans-
fected with truncated CAMGAP1. CHO (A) or COS-7 (B) cells were
transiently transfected with HA-tagged CAMGAP1 constructs and
incubated with Oregon green-conjugated transferrin. The expression of
CAMGAP1 fragment was detected by anti-HA antibody (red, left
column). The intracellular small spots indicate the uptake of transferrin
(green, middle column). The bright ﬁeld images are shown in right
column. Shown are the images observed in more than 50% of the 50
transfected cells. The construct of three WW domains contains the
region covering amino acids 101–451, the same region expressed in the
R6 construct in Fig. 4C.showed that the region of CAMGAP1 containing the proline-
rich region is associated with CIN85 (Fig. 5B). The results are
consistent with those of pull-down and overlay assays (Fig. 4)
and indicate the intracellular binding between CAMGAP1
and CIN85.
Recent works have shown that CIN85 is a scaﬀolding pro-
tein involved in regulation of clathrin-mediated endocytosis of
several plasma membrane receptors [2–4], raising the possi-
bility that CAMGAP1 may be implicated in the endocytic
process as well. To address the possible role of CAMGAP1, we
tested the eﬀect of expression of various portions of CAM-
GAP1 on the receptor-mediated endocytosis of transferrin.
Transferrin uptake was inhibited by expression of the three
WW domains of CAMGAP1 and not by expression of the
other portions of CAMGAP1 or of the full-length CAMGAP1
(Fig. 6A). The same eﬀect was also observed in COS-7 cells
(Fig. 6B). The result suggests the involvement of CAMGAP1
in transferrin receptor endocytosis.
In conclusion, we here describe the biochemical properties of
a novel Rho GAP, CAMGAP1. One of the most prominent
functions of Rho GTPases is the regulation of actin cytoskel-
etal rearrangement [26–28]. Actin dynamics plays a role in
clathrin-mediated endocytosis in mammalian cells and several
reports suggest that Rho GTPases are involved in the endo-
cytic process [6,29]. The previous report has shown that en-
dophilin binds to the proline-rich domain of CIN85 [4] and our
results indicate that CAMGAP1 associates with the SH3-B
domain of CIN85. It is possible that CAMGAP1 and endo-
philin might simultaneously interact with CIN85 and co-op-
erate functionally in the same cellular process. Our results also
suggest that CAMGAP1 might be implicated in transferrin-
receptor-mediated endocytosis by binding to unknown pro-
teins through its three WW domains, as overexpression of
these domains of CAMGAP1 produced an inhibitory eﬀect on
transferrin uptake.Taken together with the result of the in vi-
tro studies that CAMGAP1 has GAP activity toward Rac1/
Cac42, we speculate that CAMGAP1 may play a role in the
regulation of actin cytoskeletal organization during clathrin-
mediated endocytosis. It is worth noting that CMS/CD2AP, a
protein closely related to CIN85, interacts with Arp2/3 com-
plex via the binding to cortactin, suggesting a functional link
between the CIN85 family of adaptor proteins and actin or-
ganization [30]. Further investigation is needed to obtain more
direct evidence to understand the physiological function of
CAMGAP.
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